NIH Backs $13.1 Million Effort to Attack Breast Cancer with Engineered Salmonella
A five-year, $13.1 million NIH grant will fund engineered, nontoxic Salmonella designed to deliver radiopharmaceutical therapy, viral payloads, and immune-targeting ...
